Get the Stockscreener App
8.29
5.90%
-0.52
After Hours:
8.32
0.03
+0.36%
Anavex Life Sciences Corporation Stock (AVXL) Latest News
Analytical Lens: Exploring Anavex Life Sciences Corporation (AVXL)’s Financial Story Through Ratios - The Dwinnex
Anavex Life Sciences Corporation (AVXL) receives a Neutral rating from Cantor Fitzgerald - Knox Daily
Anavex Life Sciences Corporation (AVXL) Stock: Assessing the Risk and Reward - The News Heater
Anavex Life Sciences (AVXL) to Release Quarterly Earnings on Wednesday - MarketBeat
Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025 - The Manila Times
Anavex Q1 2025 Earnings: Strategic Growth Updates Coming February 12 - StockTitan
Anavex Life Sciences (AVXL) to Release Earnings on Wednesday - MarketBeat
JPMorgan Chase & Co. Acquires 1,191 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Receives "Buy" Rating from D. Boral Capital - MarketBeat
HC Wainwright Reaffirms Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Jim Cramer on Anavex Life Sciences Corp. (AVXL): ‘It’s A Good Spec’ - Yahoo Finance
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from D. Boral Capital - Defense World
Anavex Life Sciences Secures New Patent For ANAVEX®2-73 - Evrim Ağacı
NASDAQ: AVXL Lawsuit Update: Investors Who Lost Money With Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) Should Contact the Shareholders Foundation - ACCESS Newswire
Anavex Life Sciences Secures New U.S. Patent For ANAVEX 2-73 Or Blarcamesine - RTTNews
Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio - The Manila Times
Anavex Secures Crucial Patent for Alzheimer's Drug Delivery Breakthrough - StockTitan
Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why - Nasdaq
Anavex Life Sciences’ (AVXL) Buy Rating Reaffirmed at HC Wainwright - Defense World
Long-Term investors in shares of Anavex Life Sciences Corp. - openPR
Best Momentum Stocks to Buy for January 21st - Yahoo Finance
New Strong Buy Stocks for January 21st - Yahoo Finance
SeaCrest Wealth Management LLC Invests $164,000 in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz - MSN
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 9.4%What's Next? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Shares Down 6.3%Time to Sell? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Shares Up 9.4%Here's Why - MarketBeat
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer's Disease - The Manila Times
Anavex's Oral Alzheimer's Drug Shows Breakthrough 36% Disease Slowdown in Phase 3 Trial - StockTitan
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stock Holdings Raised by Barclays PLC - MarketBeat
Barclays PLC Acquires 64,101 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Dru - Asianet Newsable
Anavex Life Sciences: Pioneering Precision Medicine for CNS Disorders - Big News Network
Anavex Life Sciences (NASDAQ:AVXL) Receives “Buy” Rating from D. Boral Capital - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Receives Buy Rating from D. Boral Capital - MarketBeat
New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer's Disease Patients - The Manila Times
Anavex Life Sciences (NASDAQ:AVXL) vs. Pluri (NASDAQ:PLUR) Critical Comparison - Defense World
Playing The Odds Of Anavex Alzheimer's Drug Approval (NASDAQ:AVXL) - Seeking Alpha
The Misconceptions About Anavex Life Sciences' Blarcamesine Phase 2b/3 Trial In Alzheimer's Disease - Seeking Alpha
Commit To Buy Anavex Life Sciences Corp At $7, Earn 28.6% Using Options - Nasdaq
Jane Street Group LLC Sells 119,531 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat
Jane Street Group LLC Trims Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 11.3%What's Next? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Trading 6.3% HigherStill a Buy? - MarketBeat
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):